Arlington Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-34
| Closed | -$11.8K | – | 395 |
|
|
2023
Q3 | $11.8K | Hold |
34
| – | – | ﹤0.01% | 220 |
|
|
2023
Q2 | $12K | Sell |
34
-66
| -66% | -$23.2K | ﹤0.01% | 447 |
|
|
2023
Q1 | $31.5K | Buy |
+100
| New | +$31.5K | ﹤0.01% | 299 |
|
|
2022
Q1 | – | Sell |
-49
| Closed | -$11K | – | 658 |
|
|
2021
Q4 | $11K | Buy |
+49
| New | +$11K | ﹤0.01% | 461 |
|
|
2020
Q2 | – | Sell |
-46
| Closed | -$11K | – | 289 |
|
|
2020
Q1 | $11K | Hold |
46
| – | – | 0.01% | 163 |
|
|
2019
Q4 | $10K | Buy |
+46
| New | +$10K | 0.01% | 197 |
|
|
2019
Q1 | – | Sell |
-46
| Closed | -$8K | – | 240 |
|
|
2018
Q4 | $8K | Buy |
+46
| New | +$8K | 0.01% | 174 |
|